Lam Research (LRCX) Q2 FY2026 Post-Earnings Debrief

1. Executive Summary

2. What Actually Mattered

The Q2 FY2026 print contained several headline beats, but the items that truly moved the investment debate were narrower than the full results table would suggest.

3. Results Versus Expectations

Revenue and EPS exceeded both consensus and the company's own guidance midpoints. The revenue beat was modest at 2.2%, and sequential growth was essentially flat at +0.4% Q/Q — a notable deceleration from the +2.9% Q/Q in Q1 FY2026 and +9.6% Q/Q in Q4 FY2025. The gross margin miss versus consensus was the key blemish: while the 49.6% result was at the high end of company guidance (49% ± 1pp), the Street had modeled 50.02%, reflecting expectations that margin expansion had further room to run. The miss was driven by customer mix — China revenue declined from 43% to 35% of total, and non-China customers carry modestly lower margins at the system level.

4. Historical Quarterly Comparison

The historical trajectory reveals a company in the late stages of a powerful cyclical ramp. Revenue nearly doubled from $3.87B (Q4 FY2024) to $5.34B in six quarters, but the Q/Q growth rate has decelerated from +9.6% in Q4 FY2025 to essentially flat in Q2 FY2026. Gross margin peaked at 50.43% in Q1 FY2026 and has started pulling back. Operating margin peaked at 34.35% in the same quarter. The combination of slowing sequential revenue growth and compressing margins is the first time in six quarters that both metrics moved in the wrong direction simultaneously — a watchpoint for forward modeling, though guided Q3 revenue reaccelerates to +6.7% Q/Q.

5. Guidance Bridge and Implications

Year-on-Year Guidance Step-Up (March Quarter)

The Q3 FY2026 guidance was the most important data point from the print. Revenue guidance midpoint of $5.7B represented a 6.7% sequential acceleration from a nearly flat Q2 — signaling that the revenue deceleration was temporary, not structural. The guidance implied the Street's pre-earnings estimate for Q3 ($5.31B) was ~$390M too low, triggering the massive forward estimate revision.

Gross margin guided to 49% at midpoint for Q3 reflects continued customer mix headwinds as China declines as a percentage of total revenue. Management attributed this to the geographic and customer composition of the order book, not to pricing pressure or cost challenges. The critical nuance: operating margin was guided higher (34% midpoint) despite lower gross margin, implying management is pulling opex levers to protect profitability through the mix transition.

Full-Year Directional Guidance

Management guided WFE 2026 to ~$135B (vs. ~$110B actual 2025, a 23% step-up), with the constraint being clean room availability rather than equipment demand. Revenue is expected to grow every quarter sequentially through FY2026, with second-half weighting. China revenue is expected to be "flattish" absolute in CY2026, declining as a percentage of total to the low 30s or high 20s. Advanced packaging revenue is expected to grow >40% in 2026. Capital returns will target at least 85% of free cash flow.

6. Estimate Revision Implications

The earnings event triggered a massive one-time upward revision in forward estimates, with Q3 FY2026 EPS surging 13.2% and revenue 7.3% in the 48 hours post-print. Since then, estimates have been completely stable — no incremental revisions in 4+ weeks. Revision momentum has fully exhausted. The full-year and FY2027 estimates imply 24.4% revenue growth in FY2027 and 31.4% EPS growth, reflecting the Street's confidence in the WFE upcycle thesis.

The key risk to current estimates: gross margin trajectory. If China revenue declines further as a percentage (as guided), and non-China customers carry structurally lower system-level margins, the 49.6% gross margin consensus for FY2026 may prove optimistic. Conversely, if the operating leverage ahead-of-model dynamic persists, operating income estimates may prove conservative even if gross margin compresses.

7. Transcript Intelligence

Prepared Remarks — Key Themes

CEO Tim Archer opened with a confident tone, declaring 2025 a "record year on all metrics" and positioning CY2026 as an acceleration phase driven by the AI transformation. The framing shifted markedly from prior quarters' "strong execution" language to "AI transformation driving industry spending higher" — a deliberate narrative upgrade. WFE for 2025 came in at ~$110B (vs. prior guidance of ~$100B, a ~10% beat), and 2026 was guided to ~$135B with the constraint being physical clean room space, not equipment demand or end-market weakness.

CFO Doug Bettinger anchored the financial narrative around operating leverage, noting that the company is already running at its Investor Day long-term margin targets ($28B revenue model) despite operating at only ~$21B annualized revenue. He explicitly flagged a model update later in 2026, which management-watchers should read as a strong signal of raised long-term targets.

Three new disclosure points were notable: (1) AI inference as a NAND demand driver (KB cache for large language models), adding ~1 percentage point of incremental NAND bit demand per 2-3 million accelerators sold — a first-time acknowledgment; (2) Aqara conductor etch doubling its installed base in one year with production tool-of-record wins; (3) Dextro cobots expanding to 6 Lam tool types with multiyear services agreements, transitioning from pilot to commercial scale.

Q&A Intelligence

Analyst questions clustered around four themes: (1) gross margin trajectory and China mix (Arcuri/UBS, Muse/Cantor, Rasgon/Bernstein), (2) NAND upgrade timeline and greenfield pivot (Schneider/GS, Arya/BofA, Weathers/DB), (3) WFE $135B framework and clean room constraints (Arcuri/UBS, Sur/JPM), and (4) share gain quantification (Arya/BofA, Poojary/RBC). Management was notably direct on most topics — the evasion was limited to timing specifics on the Investor Day model update and precise customer-level mix dynamics.

The most important Q&A exchange was Tim Arcuri (UBS) pressing on the WFE "clean room gap" — effectively asking management to quantify how much WFE demand exceeds physical fab capacity. Archer declined to give a specific number but reinforced the structural supply constraint narrative. Doug Bettinger's response to the 2027 outlook question was unusually forward-leaning for Lam management: "it sets up for '27 to also be a pretty good year...everybody's talking about these multiyear agreements."

Stacy Rasgon (Bernstein) tested whether China commentary was market-wide or Lam-specific, extracting the important confirmation that China revenue is expected to be "flattish" absolute — meaning the percentage decline is purely a denominator effect from non-China growth, not a reduction in China demand.

Cross-Quarter Language Comparison (Dec 2024 vs. Dec 2025)

Management Quotes — Grouped by Theme

WFE Outlook and Industry Constraints

"Our initial 2026 view is for WFE to be in the $135 billion range, with the growth in spending remaining constrained by a shortage of available clean space. Chipmakers have been public about their efforts to alleviate constraints, but they have also commented on sold out conditions persisting, indicating the magnitude of the challenge." — Tim Archer, CEO

"I think it's safe to say...it sets up for '27 to also be a pretty good year...The industry seems to be sold out for most of what it's supplying and everybody's talking about these multiyear agreements that they're working on." — Doug Bettinger, CFO

Record Results and Execution

"We ended calendar year 2025 on a strong note, delivering December quarter revenues ahead of the midpoint of our guidance. Gross margins, operating margins, and EPS all exceeded the high end of the range." — Tim Archer, CEO

"In calendar year 2025, revenue was a record coming in at $20.6 billion, which is up 27% year over year. CSBG revenue also reached a record of $7.2 billion. Gross margin was 49.9%, the highest result as a combined company for the full year since the Novellus merger back in 2012." — Doug Bettinger, CFO

NAND AI Inference Demand Driver

"Non-volatile context memory layers that enable large scale AI inference have the potential to add incremental growth in NAND bit demand for every 2 to 3 million accelerators sold. We estimate an incremental one point increase in overall NAND bit demand growth." — Tim Archer, CEO

"The specific wording we used at Investor Day was '40 billion over several years.' We've now, almost every earnings call said that seems to be happening faster than expected...NAND is moving faster than we expected on the upgrade path." — Tim Archer, CEO

Share Gain and Product Momentum

"We plan to increase our share of WFE again this year. And what needs to take place is technology transitions need to keep occurring. And what we're seeing in the environment today is those are accelerating." — Tim Archer, CEO

"Our latest generation conductor etch system has doubled its installed base over the past year, with production tool of record wins for EUV and high aspect ratio etch applications in advanced DRAM and foundry logic." — Tim Archer, CEO

Operating Leverage and Long-Term Model

"The vision we shared was to more than double Lam's revenue and profit over the next five years. Today, we are well on our way with the industry ramping capacity and adopting new technologies to meet the demands of the AI transformation." — Tim Archer, CEO

"We probably later in the year need to come out and give you an update on that model. Lots have changed in the last year or so. We're run rating at least on a percentage basis what the model suggests we're going to be able to do [at $28B revenue]." — Doug Bettinger, CFO

China and Geographic Mix

"We are looking at China being a more kind of flattish year on year and therefore, as the rest of the technology driven part of the business grows, becoming a smaller percentage of our overall revenue." — Tim Archer, CEO

Forward Guidance and Revenue Shape

"We're expecting revenue of $5.7 billion, plus or minus $300 million. In gross margin of 49%, plus or minus one percentage point... We're forecasting earnings per share of $1.35 plus or minus $0.10." — Doug Bettinger, CFO

"I think we're going to see growth every quarter from the previous quarter...March quarter...June probably grows from that...September from that. And it ends up being the second half weighted year." — Doug Bettinger, CFO

8. Segment and KPI Forensic Review

Systems Revenue by End Market — December 2025 Quarter

The most important segment-level development was the dramatic DRAM/NAND mix shift within memory. DRAM surged to a record 23% of systems revenue (from 16% in Q1), driven by HBM3/4 and DDR5 1-billion/1-charlie node transitions. NAND declined to 11% (from 18%), which management characterized as in-line with expectations — the upgrade cycle is temporarily pausing as customers absorb installed capacity before the greenfield build-out expected in 2027-2028. Foundry remains dominant at 59%, up dramatically from 35% a year ago, reflecting the AI-driven wafer start ramp at leading-edge nodes.

Regional Revenue Mix

CSBG (Customer Support and Related Revenue)

CSBG revenue reached ~$2.0B in Q2 FY2026, up 12% sequentially and 14% year-over-year, with the installed base topping the 100,000 chamber milestone. Full-year CY2025 CSBG was a record $7.2B. Upgrade revenue grew >90% year-over-year in CY2025, driven by NAND layer count upgrades and memory node transitions. The installed base growth provides a durable, high-margin revenue floor — CSBG is now annualizing at ~$8B, representing roughly 36% of total revenue.

Balance Sheet and Capital Allocation

Share buybacks of ~$1.4B at an average price of ~$154/share in Q2 were aggressive. Full-year CY2025 buybacks totaled ~39M shares at an average of ~$104/share — well below the current price and representing excellent capital allocation. The $750M March 2026 notes will be repaid from cash, temporarily reducing the cash balance. Board repurchase authorization remaining: $5.1B. Free cash flow return target of 85% is being met, with TTM FCF of $5.4B (2.2% FCF yield on current market cap). Inventory turns improved to 2.7x from 1.5x two years ago, reflecting better supply chain execution.

9. Quality of the Quarter

• Revenue Quality: High. Record revenue was driven by organic demand across foundry and memory, not pull-forwards or channel fill. Sequential growth was near-flat, but this was a function of timing (China declining, NAND temporarily pausing) rather than demand deterioration. The 10th consecutive quarter of revenue growth is a real trend.
• Margin Quality: Mixed. Gross margin at 49.6% was at the high end of guidance but missed consensus and compressed 83bps Q/Q. The compression was mix-driven (China declining as a percentage, non-China customers at lower system margins) rather than pricing-pressure or cost-inflation driven. Operating margin at 33.87% was at the high end of guidance, demonstrating opex discipline. The gap between gross margin compression and operating margin resilience reflects genuine operating leverage.
• EPS Quality: High. Non-GAAP EPS beat of 4.2% was driven by operating performance, not tax rate benefits or share count changes (diluted shares were in-line at 1.26B). No material one-time items or below-the-line support.
• Cash Flow Quality: High. TTM FCF of $5.4B remains robust. DSO improved by 3 days to 59. Inventory turns improved to 2.7x. The deferred revenue decline of ~$500M is worth monitoring but not yet alarming — customer advance payments can be lumpy.
• Working Capital: Improving. DSO and inventory turns both improved, and CapEx increased to $261M (up $76M Q/Q) to support manufacturing expansion including the new Arizona building. CapEx at 4-5% of revenue is disciplined relative to growth.

10. Options and Volatility Diagnostics

Options pricing on LRCX reflects extreme uncertainty at near-record levels. The 30-day ATM implied volatility of 72.5% sits at the 98.8th percentile of its one-year distribution — meaning only 2 of the past 255 trading days have seen higher IV. Notably, the IV did not crush after earnings as is typical; instead, it expanded from 57% pre-print to 66% a week later, and has continued climbing to 72.5% on the back of sustained sector weakness and macro/tariff uncertainty. This is consistent with institutional hedging activity rather than speculative positioning — the put/call OI ratio of 1.21x confirms modest but not extreme protective demand.

Market Reaction

Technical Levels

11. Stock Reaction Drivers

The D0 reaction of -5.93% (vs. SOX -3.87%) reflected three factors: (1) gross margin miss and guided compression, which raised questions about the sustainability of the margin expansion story; (2) near-flat sequential revenue growth (+0.4% Q/Q), creating a "peak revenue growth" narrative; and (3) macro overhang from tariff/trade policy uncertainty that was weighing on the entire semiconductor equipment complex.

The subsequent deterioration from D0 to Week+1 (-14.1% vs. SOX -8.5%) was disproportionate and likely driven by institutional position trimming — portfolio managers reducing WFE exposure on the combination of cycle-peak concerns and macro uncertainty. The 557bps of underperformance versus SOX suggests Lam-specific selling beyond sector rotation, potentially triggered by the gross margin trajectory and China revenue composition concerns.

The continued decline to -19.7% cumulative (through March 9) tracks with broader semiconductor correction and is no longer primarily earnings-driven. Short interest at 2.65% of float is too low to be driving the move — this is long-only selling, not a short squeeze candidate. The stock now trades below every single analyst price target on the Street, a rare dislocation that either signals the market is ahead of consensus in repricing cycle risk, or represents an asymmetric opportunity if the WFE upcycle thesis remains intact.

12. What Mattered Less Than It Appeared

• Revenue beat of 2.2% ($112M). While positive, the sequential growth was essentially flat (+0.4% Q/Q). The "beat" was largely a function of conservative consensus, not upside surprise. The forward guide was far more important than the backward-looking beat.
• "Record" revenue framing. Revenue setting records is expected during a cyclical upcycle with 22% Y/Y growth. The more meaningful metric was the sequential deceleration, which management addressed by guiding Q3 higher (+6.7% Q/Q).
• Record CSBG revenue. CSBG growth is mechanically tied to installed base expansion (now >100,000 chambers). It is highly predictable and already well-modeled by the Street. Not incremental to the thesis.
• EPS beat quality. The 4.2% EPS beat, while high quality, was modest in magnitude ($0.05). The market was focused on forward guidance, not backward-looking pennies.
• Share buyback activity at $154/share. While evidence of management confidence, buybacks at $154 in a stock now at $199 are not a differentiating signal — management was buying below current levels, which is standard capital return execution.
• Installed base crossing 100,000 chambers. A vanity milestone. The more relevant metric is the upgrade revenue conversion rate and CSBG growth sustainability.

13. Post-Print Analyst Activity

Consensus remains overwhelmingly bullish: 27 Buy, 10 Hold, 0 Sell across 37 analysts. The mean PT of $276.42 and median of $280 imply 38.7-40.5% upside from the current $199.33 — a striking disconnect. No analyst downgraded on the print, and no notable PT cuts have emerged post-earnings, despite the stock declining 19.7%. This PT inertia is common in the early stages of a drawdown; a wave of PT reductions is probable as analysts update models for the macro/tariff overhang. The Morningstar $200 PT (lowest on the Street) is now essentially at the current price. The Susquehanna $325 (highest) reflects maximum WFE upcycle optimism.

14. Peer and Sector Read-Through

LRCX trades at a modest premium to AMAT on forward P/E (32.3x vs. 27.1x) and EV/EBITDA (26.6x vs. 22.4x), which reflects LRCX's higher exposure to the AI/NAND upgrade cycle but also its greater China revenue concentration risk. LRCX and KLAC are nearly identically valued on forward P/E (32.3x vs. 32.4x) despite different fundamental profiles — KLAC carries higher process control margins but lower revenue growth. ASML commands a premium (37.2x forward P/E) on its monopolistic EUV position. Teradyne (TER) trades at the largest premium on forward P/E (43.6x) and has the strongest YTD performance (+41.1%), reflecting its AI testing demand exposure.

LRCX's results confirm the broad WFE upcycle thesis that benefits all equipment peers. The $135B WFE 2026 outlook is constructive for AMAT and KLAC read-through. However, the gross margin compression driven by customer/geographic mix is Lam-specific and does not read through to AMAT (which has different customer mix dynamics) or KLAC (which is a higher-margin, lower-cyclicality business). The NAND upgrade acceleration is most directly bullish for LRCX given its dominant installed base in NAND etch and deposition, and secondarily constructive for AMAT.

15. Investment Implications

Bull Case Reinforcement: The operating leverage ahead-of-model dynamic is underappreciated. If Lam raises its long-term model to 36-37% operating margins at $28B revenue (vs. the current 34-35% target), FY2027-2028 EPS estimates could move materially higher. The NAND AI inference demand driver is also not yet in consensus models — incremental NAND bit demand from KB cache workloads could add $500M-$1B of revenue over the next 2-3 years. Advanced packaging growing >40% in 2026 is another underappreciated growth vector.

Bear Case Considerations: Gross margin compression from customer mix is structural and may persist. China revenue at 35% still carries meaningful geopolitical/regulatory risk. The $199 stock price is discounting WFE cycle concerns that consensus has not yet absorbed. If the macro/tariff environment deteriorates further, WFE spending could pause despite structural demand — clean room constraints don't matter if customers slow orders. The deferred revenue decline of ~$500M could be an early signal of slowing order momentum, though management has not flagged this.

Management Credibility: High. Lam has beaten revenue guidance midpoint in 10 consecutive quarters. The WFE outlook has consistently proved conservative (2025: guided ~$100B, actual ~$110B). Bettinger's forward-leaning commentary on 2027 is unusual for Lam management and should be weighted accordingly.

16. What to Watch Next

17. Appendix — Senior Executives

Executive Leadership

Research Analysts on Q2 FY2026 Call

18. Sources

Sources: Bloomberg, Lam Research Q2 FY2026 Earnings Call Transcript (January 29, 2026), Lam Research Q4 FY2024 Earnings Call Transcript (December 2024), Lam Research Q2 FY2026 Earnings Press Release, Lam Research February 2025 Investor Day Presentation